Daily SPAC Update – March 22, 2024

by | Mar 22, 2024

Trump’s DWAC + TMTG Deal Approved. RWOD + ANEW Medical Deal Vote. HSPO, TMTC Extension Votes.

Boardroom Alpha SPAC Resources
Full SPAC Listing
SPAC SEC Filings
Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

DWAC + TMTG Deal Approved

  • Will trade as DJT starting next week sometime
  • Trump’s investment is worth aproximately $3 billion
  • More at WSJ

MERGER VOTES
RWOD + ANEW Medical
DWAC + Trump Media & Technology Group Corp.

EXTENSION VOTES
HSPO – HORIZON SPACE ACQUISITION I CORP * extend to Dec 27, 2024
TMTC – TMT ACQUISITION CORP * extend to Dec 30, 2024

OTHER SPAC NEWS
DSAQ – DIRECT SELLING ACQUISITION CORP * Adjourned to March 27, 2024

YESTERDAY’S TOP SPAC GAINERS
5.48% ~ $ 11.75 | CNDB – Concord Acquisition Corp III (Announced)
5.14% ~ $ 12.30 | MCAF – Mountain Crest Acquisition Corp. IV (Announced)
3.12% ~ $ 9.50 | ARRW – Arrowroot Acquisition Corp. (Announced)
1.20% ~ $ 10.27 | WNNR – Andretti Acquisition Corp. (Announced)
1.13% ~ $ 10.73 | TWLV – Twelve Seas Investment Company II (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-64.46% ~ $ 2.85 | ADOC – Edoc Acquisition Corp (Announced)
-28.84% ~ $ 7.70 | TWOA – two (Announced)
-24.66% ~ $ 8.40 | ASCA – ASPAC I Acquisition Corp. (Announced)
-10.36% ~ $ 6.06 | APAC – StoneBridge Acquisition Corp. (Announced)
-6.51% ~ $ 8.40 | DECA – Denali Capital Acquisition Corp. (Announced)

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.